Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles

Virologica Sinica

Volumn 30, Issue 3, 2015, Pages 208-213

  Lin, Tao ^a   Xianyu, Lingzhi ^a   Lyu, Songya ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

enterovirus 71 (EV71); hand, foot and mouth disease; hybridoma; neutralizing antibodies; virus like particles (VLPs)

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D4; MONOCLONAL ANTIBODY G12; NEUTRALIZING ANTIBODY; PROTEIN VP0; PROTEIN VP1; PROTEIN VP3; UNCLASSIFIED DRUG; VIRUS PROTEIN; CAPSID PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS LIKE PARTICLE VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; CELL AGGREGATION; CELL PROTECTION; CELL SIZE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG PURITY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; FLOTATION; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; RHABDOMYOSARCOMA CELL LINE; VIRUS CHARACTERIZATION; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; ANIMAL; BAGG ALBINO MOUSE; CHINA; ENTEROVIRUS A; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PASSIVE IMMUNIZATION; PROCEDURES; SACCHAROMYCES CEREVISIAE; SEROLOGY;

HUMAN ENTEROVIRUS 71; MIRIDAE; MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHINA; ENTEROVIRUS A, HUMAN; FEMALE; IMMUNIZATION, PASSIVE; MICE, INBRED BALB C; SACCHAROMYCES CEREVISIAE; SEROLOGIC TESTS; VACCINES, SYNTHETIC; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84933673926     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-015-3573-8     Document Type: Article

References (21)

1. Baek K, Park K, Jung E, Chung E, Park J, Choi H, Baek S, Jee Y, Cheon D, Ahn G. 2009. Molecular and epidemiological characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006. J Microbiol Biotechnol, 19: 1055–1064.
2. Chang GH, Luo YJ, Wu XY, Si BY, Lin L, Zhu QY. 2010. Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virol J, 7: 106.
3. Chang HW, Liu CC, Lin MH, Ho HM, Yang YT, Chow YH, Chong P, Sia C. 2011. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates. J Virol Methods, 173: 189–195.
4. Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, Poovorawan Y. 2010. Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008–2009. Jpn J Infect Dis, 63: 229–233.
5. Chen HF, Chang MH, Chiang BL, Jeng ST. 2006. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine, 24: 2944–2951.
6. Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM. 2008. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 26: 2882–2889.
7. Chonmaitree T, Menegus MA, Schervish-Swierkosz EM, Schwalenstocker E. 1981. Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics, 67: 489–493.
8. Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, Nishio O. 2002. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000. detection and molecular epidemiology of enterovirus 71. Microbiol Immunol, 46: 621–627.
9. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med, 341: 929–935.
10. Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, Chen KT. 2009. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J, 28: 904–910.
11. Li HY, Han JF, Qin CF, Chen R. 2013. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine, 31: 3281–3287.
12. Li X, Mao C, Ma S, Wang X, Sun Z, Yi Y, Guo M, Shen X, Sun L, Bi S. 2009. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Biochem Biophys Res Commun, 390: 1126–1128.
13. Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, Wang YC, Chen YC, Yang CS, Chong PC. 2011. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS One, 6: e20005.
14. Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. 2010. Virus-like particles in vaccine development. Expert Rev Vaccines, 9: 1149–1176.
15. Singh S, Chow VT, Phoon MC, Chan KP, Poh CL. 2002. Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers. J Clin Microbiol, 40: 2823–2827.
16. Sivasamugham LA, Cardosa MJ, Tan WS, Yusoff K. 2006. Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits. J Med Virol, 78: 1096–1104.
17. Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C, Walter TS, Evans G, Axford D, Owen R, Rowlands DJ, Wang J, Stuart DI, Fry EE, Rao Z. 2012. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol, 19: 424–429.
18. Wong SS, Yip CC, Lau SK, Yuen KY. 2010. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect, 138: 1071–1089.
19. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. 2001. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine, 20: 895–904.
20. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, An HQ, Li DX, Wang SW, Xu AQ, Wang ZJ, Xu WB. 2009. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 44: 262–267.
21. Zhou SL, Ying XL, Han X, Sun XX, Jin Q, Yang F. 2015. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate. J Med Virol, 87: 256–262.